Clinical Trials Logo

Roux-en-Y Gastric Bypass clinical trials

View clinical trials related to Roux-en-Y Gastric Bypass.

Filter by:

NCT ID: NCT02128581 Completed - Obesity Clinical Trials

A Dose-response of the Effects of Exendin-9,39 on GI Symptoms and Food Intake

Start date: May 2014
Phase: Phase 1
Study type: Interventional

Exendin-(9,39) has been shown to have effects on beta-cell function, and after gastric bypass, to accelerate gastrointestinal transit. - infused at rates of 300pmol/kg/min. Given that gastrointestinal transit is typically delayed by Glucagon-Like Peptide-1 (GLP-1) and also that this hormone causes decreased food intake through increased satiation, it is reasonable to expect an effect of Exendin-9,39 on appetite. This may help explain the effects of gastric bypass on food intake. To examine the effect of Exendin on food intake we propose a dose-response study to determine whether the compound has effects in a dose-dependent fashion. We will examine the presence of gastrointestinal symptoms as well as food intake in the immediate aftermath of a test meal and the subsequent hours.

NCT ID: NCT02005107 Completed - Sleeve Gastrectomy Clinical Trials

Venlafaxine PK Following Bariatric Surgery

VLX
Start date: December 2013
Phase: Phase 4
Study type: Interventional

This study is being conducted to evaluate how the body absorbs and processes the immediate release (IR) and sustained release (XR) medication venlafaxine (Effexor®). Subject who are 1-3 years post gastric bypass or sleeve gastrectomy surgery will be invited to participate. Non-surgical controls will also be enrolled based on a matching criteria to post gastric bypass subjects. Participants will be asked to complete two 12-hour study days approximately 11 days apart. This study will enroll up to 30 participants.

NCT ID: NCT01867255 Completed - Bariatric Surgery Clinical Trials

Study to Examine the Effect of Gastric Bypass Surgery on Venlafaxine ER Blood Levels

Start date: October 2013
Phase: Phase 1
Study type: Interventional

The purpose of the study is to determine whether a significant and predictable change in bioavailability of extended-release venlafaxine occurs following Roux-en-Y gastric bypass.

NCT ID: NCT00950872 Completed - Clinical trials for Roux En Y Gastric Bypass

Safety and Efficacy Study of Duet TRS

Start date: November 2009
Phase: N/A
Study type: Interventional

The objectives of this clinical trial are the overall performance and safety of the ENDO GIA Staplers with ENDO GIA SULUs with Duet TRS TM.